Domainex significantly expands its footprint, leasing the first of three new laboratory buildings at Unity Campus Cambridge, 10th July 2023: Leading regional property investor and developer Howard Group is delighted to confirm the letting of Building A2 to Domainex, a leading integrated medicines research services partner and recent recipient of a King’s Award for Enterprise. A2 is one of three new laboratory buildings currently under construction at Unity Campus, all of which are due for completion later this year. The three-storey Building A2 of over 24,000 sq ft…

Edinburgh and Cambridge, UK, 7 July 2023 - Macomics Ltd, a leader in macrophage drug discovery, is delighted to announce that it was voted as the winner of the 2023 BioNewsRound Award for the news of its worldwide drug discovery collaboration agreement with Ono Pharmaceutical Co., Ltd. to develop new immuno-oncology antibody drugs against a novel macrophage target of interest in cancer, announced in March. Sue Charles, consultant to Macomics collecting the award from Tony Jones, CEO One Nucleus, on behalf of CEO Steve Myatt The Award, organised by leading trade association One Nucleus, seeks…

Dr Stevens promoted from Director of Drug Discovery, and Dr Kirby promoted from Director of Operations Cambridge, UK, 06 July 2023: Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, today announced the appointments of Dr Robert Kirby to Chief Operating Officer and Dr Edward Stevens to Chief Scientific Officer. Both appointments represent promotions from within the company. After relocating to larger Company headquarters in 2021and a period of rapid recruitment in 2022, Metrion’s customer base and scale of operations has continued…

Life Sciences industry entrepreneur joins the region’s Life Science & Healthcare membership organisation Cambridge, UK: 06 July 2023 - One Nucleus, the Cambridge based not-for-profit membership organisation for life science businesses, is delighted to announce the appointment of Prashant Shah, the serial deep tech entrepreneur and investor as a Non-Executive Director. Prashant is co-CEO and co-Founder of o2h, leading on the development of the Mill SciTech Park, supporting the creation of innovative life science and tech-bio companies.    Prashant’s impressive CV includes a…

Here are four interesting insights from the report: • Amid inflation, talent shortages and other disruption, savvy biotech’s are focusing on the fundamentals of preserving cash and producing strong data and evidence to showcase their overall resilience to potential investors. • In light of the recently passed Inflation Reduction Act and its impact on drug pricing, inflationary rebates and Medicare Part D redesign, biotech leaders need to take a strategic approach around commercialization, launch sequencing and other areas. • In today’s operating environment, leveraging digital capabilities is…

IPO Quarterly Report In Q2 2023, emerging markets are thriving amid a slow global IPO market. In brief • In the first half of 2023, global IPO volumes fell 5%, with proceeds down 36% YOY. • The US had its largest offering since November 2021. • Asia-Pacific continues to dominate with an approximate 60% share of global IPOs.

28 June 2023 - Private equity buyouts in the UK healthcare sector including life sciences increased 14%* in Q1 2023 and remain ahead of pre-pandemic levels, even in the face of economic headwinds. With high levels of capital available to be deployed, its expected private equity interest will continue to be elevated, says RSM UK. The life sciences sector remains resilient, helped by interest from investors, despite the current economic uncertainty and challenges around high interest rates, sourcing talent, and a shortage of lab space. However, there has been a general slowdown of deal…

Read July's eNews here

• Pioneering partnership will see the delivery of 95,000 square feet of incubator space on the South Bank of London • Split across two sites, the life sciences facilities will help incubate early-stage companies spun out of King’s College London in a boost for UK life sciences • Announcement comes just weeks after the government launched a package of measures to turbocharge growth in UK life sciences LONDON – 3 JULY, 2023 – Pioneer Group has announced a new partnership with King’s College London to launch new dedicated start-up incubators in biotech and medtech on the South Bank of London. In…

Arecor Therapeutics plc (“Arecor” or the “Group”) ARECOR ANNOUNCES ADDITIONAL AGREEMENT WITH LEADING BIOPHARMACEUTICAL COMPANY Cambridge, UK, 5 July 2023. Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical company advancing today’s therapies to enable healthier lives, announces that it has entered into an agreement with a leading biopharmaceutical company to support the ongoing development of a biosimilar product. This revenue-generating collaboration follows an earlier technology partnership between the two companies, utilising Arecor’s proprietary technology platform, Arestat™, and…